{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T09:40:34Z","timestamp":1773394834768,"version":"3.50.1"},"reference-count":10,"publisher":"Centers for Disease Control MMWR Office","issue":"01","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Morb. Mortal. Wkly. Rep."],"DOI":"10.15585\/mmwr.mm6601a6","type":"journal-article","created":{"date-parts":[[2017,1,12]],"date-time":"2017-01-12T10:31:56Z","timestamp":1484217116000},"page":"23-25","source":"Crossref","is-referenced-by-count":19,"title":["Guidance for Assessment of Poliovirus Vaccination Status and Vaccination of Children Who Have Received Poliovirus Vaccine Outside the United States"],"prefix":"10.15585","volume":"66","author":[{"given":"Mona","family":"Marin","sequence":"first","affiliation":[{"name":"Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, CDC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manisha","family":"Patel","sequence":"additional","affiliation":[{"name":"Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, CDC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Oberste","sequence":"additional","affiliation":[{"name":"Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, CDC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Pallansch","sequence":"additional","affiliation":[{"name":"Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, CDC."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6224","published-online":{"date-parts":[[2017,1,13]]},"reference":[{"key":"key-10.15585\/mmwr.mm6601a6-201701121031-R1","doi-asserted-by":"publisher","first-page":"470","DOI":"10.15585\/mmwr.mm6518a4","article-title":"Progress towards polio eradication\u2014worldwide, 2015\u20132016.","volume":"65","author":"Morales","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm6601a6-201701121031-R2","article-title":"Poliomyelitis prevention in the United States: updated recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"49","author":"CDC","year":"2000","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.mm6601a6-201701121031-R3","first-page":"829","article-title":"Updated recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding routine poliovirus vaccination.","volume":"58","author":"CDC","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm6601a6-201701121031-R4","unstructured":"Global Polio Eradication Initiative. Polio eradication and endgame strategic plan 2013\u20142018. Geneva, Switzerland: World Health Organization, Global Polio Eradication Initiative; 2013. http:\/\/polioeradication.org\/wp-content\/uploads\/2016\/07\/PEESP_EN_US.pdf."},{"key":"key-10.15585\/mmwr.mm6601a6-201701121031-R5","first-page":"699","article-title":"Introduction of inactivated poliovirus vaccine and switch from trivalent to bivalent oral poliovirus vaccine\u2014worldwide, 2013\u20132016.","volume":"64","author":"Immunization Systems Management Group of the Global Polio Eradication Initiative","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm6601a6-201701121031-R6","doi-asserted-by":"crossref","unstructured":"Sutter RW, Kew OM, Cochi SL, Aylward RB. Poliovirus vaccine-live [Chapter 26]. In: Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines. 6th ed. Philadelphia, PA: Saunders Elsevier;2012:598\u2013645.","DOI":"10.1016\/B978-1-4557-0090-5.00035-5"},{"key":"key-10.15585\/mmwr.mm6601a6-201701121031-R7","doi-asserted-by":"publisher","first-page":"763","DOI":"10.15585\/mmwr.mm6530a3","article-title":"Update on vaccine-derived polioviruses\u2014worldwide, January 2015\u2013May 2016.","volume":"65","author":"Jorba","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm6601a6-201701121031-R8","doi-asserted-by":"publisher","first-page":"770","DOI":"10.15585\/mmwr.mm6530a4","article-title":"Environmental isolation of circulating vaccine-derived poliovirus after interruption of wild poliovirus transmission\u2014Nigeria, 2016.","volume":"65","author":"Etsano","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm6601a6-201701121031-R9","unstructured":"WHO Global Action Plan to minimize poliovirus facility-associated risk after type-specific eradication of wild polioviruses and sequential cessation of oral polio vaccine use (GAPIII). World Health Organization, Geneva, Switzerland, 2015. http:\/\/polioeradication.org\/wp-content\/uploads\/2016\/12\/GAPIII_2014.pdf"},{"key":"key-10.15585\/mmwr.mm6601a6-201701121031-R10","first-page":"591","article-title":"Interim CDC guidance for polio vaccination for travel to and from countries affected by wild poliovirus.","volume":"63","author":"Wallace","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["MMWR. Morbidity and Mortality Weekly Report"],"original-title":[],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T08:55:16Z","timestamp":1568710516000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/66\/wr\/mm6601a6.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,13]]},"references-count":10,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2017,1,13]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.mm6601a6","relation":{},"ISSN":["0149-2195","1545-861X"],"issn-type":[{"value":"0149-2195","type":"print"},{"value":"1545-861X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,1,13]]},"published":{"date-parts":[[2017,1,13]]}}}